94 related articles for article (PubMed ID: 28315414)
1. The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy.
Lee S; Laiman A; French MA; Flexman J; Watson MW; Price P
Clin Immunol; 2017 Jun; 179():54-63. PubMed ID: 28315414
[TBL] [Abstract][Full Text] [Related]
2. Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy.
Lee S; Saraswati H; Yunihastuti E; Gani R; Price P
Clin Immunol; 2014 Dec; 155(2):149-59. PubMed ID: 25283333
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
Bailey JR; Dowd KA; Snider AE; Osburn WO; Mehta SH; Kirk GD; Thomas DL; Ray SC
J Infect Dis; 2015 Sep; 212(6):914-23. PubMed ID: 25754978
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
6. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
9. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
10. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
[TBL] [Abstract][Full Text] [Related]
11. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.
Massanella M; Tural C; Papagno L; Garcia E; Jou A; Bofill M; Autran B; Clotet B; Blanco J
Antivir Ther; 2010; 15(3):333-42. PubMed ID: 20516553
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
Lauer GM; Nguyen TN; Day CL; Robbins GK; Flynn T; McGowan K; Rosenberg ES; Lucas M; Klenerman P; Chung RT; Walker BD
J Virol; 2002 Mar; 76(6):2817-26. PubMed ID: 11861849
[TBL] [Abstract][Full Text] [Related]
13. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
14. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
[TBL] [Abstract][Full Text] [Related]
15. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
[TBL] [Abstract][Full Text] [Related]
16. CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients.
Avelino-Silva VI; Miyaji KT; Mathias A; Costa DA; de Carvalho Dias JZ; Lima SB; Simoes M; Freire MS; Caiaffa-Filho HH; Hong MA; Lopes MH; Sartori AM; Kallas EG
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):189-95. PubMed ID: 26361176
[TBL] [Abstract][Full Text] [Related]
17. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.
Kim AY; Lauer GM; Ouchi K; Addo MM; Lucas M; Schulze Zur Wiesch J; Timm J; Boczanowski M; Duncan JE; Wurcel AG; Casson D; Chung RT; Draenert R; Klenerman P; Walker BD
Blood; 2005 Feb; 105(3):1170-8. PubMed ID: 15459014
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Dominguez S; Ghosn J; Valantin MA; Schruniger A; Simon A; Bonnard P; Caumes E; Pialoux G; Benhamou Y; Thibault V; Katlama C
AIDS; 2006 May; 20(8):1157-61. PubMed ID: 16691067
[TBL] [Abstract][Full Text] [Related]
19. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.
Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B;
AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.
Liu L; Nardo D; Li E; Wang GP
AIDS; 2016 Mar; 30(5):691-700. PubMed ID: 26645605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
